Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Johnson & Johnson Expects 2024 Adjusted EPS Of $10.57–$10.72 Versus Consensus Of $10.66 And Prior Guidance Of $10.55–$10.75, With Adjusted Operational EPS Of $10.60–$10.75

Author: Benzinga Newsdesk | April 16, 2024 06:26am

Posted In: JNJ

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist